Schedule 13G ownership disclosure
AXOVANT GENE THE
Security class unavailable · CUSIP: G0750W203
Event date: 2020-02-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.9600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-20-000643
- Form type
- SC 13G
- Filer
- Sio Gene Therapies Inc.
- CIK
- CIK 1636050
- Filed
- Feb 25, 2020
- Reporting period
- Feb 20, 2020
- Description
- Schedule 13G beneficial ownership